
Cellev8 Nutrition Inc.
CELVOTCTechnology● Active
$0.08
+$0.00(+0.00%)
Market Cap$10718822
P/E Ratio—
52W High$0.89
52W Low$0.03
Cellev8 Nutrition Inc. (CELV) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CELV · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-11 | 2024-11 | 2023-11 | 2022-11 | 2021-11 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.28M | $0.20M | $0.23M | $0.03M | $0.02M |
| Cost of Revenue | $0.46M | $0.50M | $0.10M | $0.02M | $0.01M |
| Gross Profit | ($0.18M) | ($0.30M) | $0.13M | $0.01M | $0.01M |
| Gross Margin %(computed) | -63.11% | -151.47% | 56.70% | 36.37% | 35.66% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $1.32M | $0.92M | $0.76M | $0.38M | $0.46M |
| Operating Income | ($1.50M) | ($1.22M) | ($0.63M) | ($0.37M) | ($0.45M) |
| Operating Margin %(computed) | -526.79% | -613.14% | -269.24% | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.09M | $0.12M | $0.09M | $0.12M | $0.12M |
| Income Before Tax | ($1.59M) | $0.26M | ($0.73M) | ($0.49M) | ($0.57M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($1.59M) | $0.26M | ($0.73M) | ($0.49M) | ($0.57M) |
| Net Margin %(computed) | -559.09% | 132.83% | -309.10% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $0.00 | $-0.01 | $-0.00 | $-0.01 |
| Wtd Avg Shares | 134.07M | 120.11M | 112.48M | 103.44M | 95.78M |
| EBITDA | ($1.50M) | $0.39M | ($0.63M) | ($0.36M) | ($0.45M) |
| EBITDA Margin %(computed) | -526.78% | 196.33% | -266.94% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Cellev8 Nutrition Inc. data
About Cellev8 Nutrition Inc. (CELV) Income Statement
Cellev8 Nutrition Inc. (CELV) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CELV reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -63.11%), and net income of ($0.00B) — a net profit margin of -559.09%.
Frequently asked questions
CELV · 4 questionsCellev8 Nutrition Inc. (CELV) reported revenue of $0.00B for 2025, up 42.8% year-over-year.
CELV revenueCELV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08